Similar Papers

Paper Title
Journal
Date
Author
О НОВЫХ ДИАГНОСТИЧЕСКИХ ВОЗМОЖНОСТЯХ CD138 (СИНДЕКАНА-1) ПРИ МНОЖЕСТВЕННОЙ МИЕЛОМЕ
-
18 Dec 2015
Novel therapies for multiple myeloma.
Toshiaki Hayashi ... Kenneth C Anderson
British Journal of Haematology | VOL. 120
Toshiaki Hayashi, et. al.Toshiaki Hayashi ... Kenneth C Anderson
20 Dec 2002
Proteomic Profiling of Multiple Myeloma Plasma Cells and Normal Plasma Cells Reveals Differential Expression of Clu1 and Basp1 Proteins
Dominik Dytfeld ... Andrzej J Jakubowiak
Blood | VOL. 116
Dominik Dytfeld, et. al.Dominik Dytfeld ... Andrzej J Jakubowiak
19 Nov 2010
CD70/CD27 Signaling Promotes Expansion of Clonal Plasma Cells in Multiple Myeloma and Is a Promising Therapeutic Target in Advanced Disease
Stefan Forster ... Adrian Ochsenbein
Blood | VOL. 142
Stefan Forster, et. al.Stefan Forster ... Adrian Ochsenbein
28 Nov 2023
View more papers

More From: British journal of haematology

Paper Title
Journal
Date
Author
Fibrinogen genotypes and their impact on recurrence of venous thromboembolism and family history: A prospective population-based study.
Ashfaque A Memon ... Kristina Sundquist
British journal of haematology | VOL. -
Ashfaque A Memon, et. al.Ashfaque A Memon ... Kristina Sundquist
19 Jan 2025
CAR T access and outcomes in large B-cell lymphoma according to ethnicity and socioeconomic deprivation in the UK.
Diana Dragoi ... Andrea Kuhnl
British journal of haematology | VOL. -
Diana Dragoi, et. al.Diana Dragoi ... Andrea Kuhnl
16 Jan 2025
Metastatic melanoma presenting with leucoerythroblastic blood film.
Carlo Zaninetti ... Adrian Schwarzer
British journal of haematology | VOL. -
Carlo Zaninetti, et. al.Carlo Zaninetti ... Adrian Schwarzer
15 Jan 2025
JAK2 is a critical therapeutic target in VEXAS syndrome treated with ruxolitinib.
Andrea Ceccardi ... Gabriele Zoppoli
British journal of haematology | VOL. -
Andrea Ceccardi, et. al.Andrea Ceccardi ... Gabriele Zoppoli
15 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.